ERYTHROMYCIN OPHTHALMIC OINTMENT USP: Sterility Concerns
Last updated
Summary
Product
ERYTHROMYCIN OPHTHALMIC OINTMENT USP
Issue
Health products - Product quality
What to do
Consult your health care professional if you have any health concerns.
Affected products
| Brand | Product Name | Market Authorization | Dosage Form | Strength | Lot |
|---|---|---|---|---|---|
| STERI-MED PHARMA INC. | ERYTHROMYCIN OPHTHALMIC OINTMENT USP | DIN 02326663 | Ointment | ERYTHROMYCIN 5 MG/G | 2024K02, 2024J04 |
Issue
The sterility of the product might be compromised in the affected lots.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Retailers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
STERI-MED PHARMA INC.
242, Rue Saint-Cyrille Ouest
Upton, QC
J0H 2E0
Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type II
Identification number
RA-81307
Get notified
Receive emails about new and updated recall and safety alerts.